David Liu
Senior Director - Analytical Chemistry Exelixis, Inc.
David Liu is a Senior Director of Analytical Chemistry at Exelixis, where he leads the analytical development for oncology programs, including ADCs and small molecule drugs. With over 20 years of experience in biotechnology and pharmaceuticals, he has held key leadership roles at companies including Kezar Life Sciences, Nurix Therapeutics, and Gilead Sciences. His expertise spans the entire CMC development lifecycle, from early-stage research to regulatory filings. Previously, David co-founded a diagnostics company and contributed to pioneering work in sequencing chemistry at Intel. He holds a PhD and is a seasoned leader known for implementing innovative analytical methodologies that accelerate drug development.
